Arthritis and joint pain
Almost everyone knows someone with arthritis, and most people picture the same thing: stiff, aching hands, slowing down with age. That picture is real but it is only a sliver of the truth. “Arthritis” is not one disease at all — it is an umbrella word, stretched over more than a hundred different conditions, that simply means a joint has become inflamed. Some are the slow wear of a lifetime; some are the immune system turning on the body; one is caused by tiny crystals; one strikes children. They share a symptom and almost nothing else. This page is for anyone who wants to understand what is actually happening inside an arthritic joint, why the types differ so sharply, how doctors tell them apart, and what modern treatment can — and cannot yet — do. For the formal overview, the NHS arthritis pages and the UK charity Versus Arthritis are good companions to it.
What arthritis actually is
The word is built from two Greek pieces: arthron, a joint, and the suffix -itis, inflammation. So at root “arthritis” means nothing more specific than joint inflammation. That is deliberately broad, because the conditions filed under it arrive by very different routes and only meet at the joint. The CDC and WHO both treat it as a family of musculoskeletal conditions rather than a single illness, and the US institute that studies it, NIAMS, counts more than 100 distinct types.
To see what can go wrong, it helps to know what a healthy joint looks like. Most of the joints that hurt — knees, hips, knuckles, the spine — are synovial joints, the body's free-moving hinges and ball-and-sockets. In one, the two bone ends are each capped with articular cartilage: a smooth, slippery, rubbery layer that lets the bones glide over one another with almost no friction and cushions the shock of every step. The whole joint is sealed inside a tough capsule, lined on the inside by a thin membrane called the synovium. The synovium secretes synovial fluid, a slick lubricant a little like egg white that nourishes the cartilage (which has no blood supply of its own) and keeps everything moving sweetly. The gap holding that fluid is the joint space.
Arthritis is, in essence, the breakdown of this neat arrangement. In some types the cartilage itself wears thin and the joint space narrows; in others the synovium becomes inflamed and swollen and starts to attack the joint from within; in others still, crystals or misdirected immune cells crash the party. The figure below shows a healthy joint beside an osteoarthritic one, the most familiar form of damage.
The main types
Because “arthritis” covers so much ground, the single most useful thing to know is which arthritis. The split that matters most clinically is between the degenerative sort, where a joint wears down mechanically, and the inflammatory sort, where the immune system drives the damage — because they are treated in completely different ways. The table sets out the common types, what causes them, where they typically strike, and the hallmark that gives each away.
| Type | Underlying cause | Typical joints | Hallmark |
|---|---|---|---|
| Osteoarthritis | Degenerative — cartilage wears down with use, age and load | Knees, hips, hands, spine, big toe | Pain on use, eases with rest; brief morning stiffness |
| Rheumatoid arthritis | Autoimmune — immune system attacks the synovium | Small joints of hands and feet, usually symmetrical | Prolonged morning stiffness; warm, swollen joints; systemic |
| Gout | Urate (uric-acid) crystals deposited in the joint | Classically the big-toe joint; also ankle, knee | Sudden, severe, red-hot attacks, often overnight |
| Psoriatic arthritis | Autoimmune, linked to the skin condition psoriasis | Fingers/toes (whole-digit swelling), spine, knees | “Sausage” digits, nail pitting, skin plaques |
| Ankylosing spondylitis | Autoimmune inflammation of the spine and pelvis | Spine and sacroiliac joints (lower back, buttocks) | Stiff back better with movement; can fuse the spine |
| Juvenile idiopathic arthritis | Autoimmune; arises in children under 16 | Varies — knees, wrists, ankles; sometimes few or many joints | Persistent childhood joint swelling; can affect the eyes |
| Lupus-related arthritis | Part of systemic lupus, an autoimmune disease | Small joints of hands, wrists, knees, symmetrical | Joint pain with wider lupus features (rash, fatigue) |
Osteoarthritis is by far the most common, affecting many millions; the inflammatory types are rarer but tend to be more aggressive if left untreated. The split — mechanical versus immune — is the hinge on which everything that follows turns.
Osteoarthritis in depth
Osteoarthritis (OA) is the one most people simply call “arthritis”. It is centred on the articular cartilage: over years, the smooth cap on the bone ends frays, softens and thins. As it goes, the bones move closer together (the narrowed joint space on an X-ray), the exposed bone thickens, and the joint tries clumsily to repair itself by growing the bony spurs called osteophytes at the edges — the knobbly knuckles of an older hand. The result is pain, stiffness and a grating sensation, worst in the weight-bearing joints: knees, hips and the base of the thumb, plus the spine. The NHS osteoarthritis pages set out the day-to-day picture.
Who gets it? Age is the biggest factor — cartilage has limited capacity to repair, so decades of use take a toll — but OA is not an inevitable part of ageing, and plenty of older people never develop troublesome disease. Other strong drivers are being female (especially after menopause), a family history, previous joint injury (a footballer's old knee), jobs or sports with heavy repetitive loading, and, importantly, excess body weight.
The weight link is worth dwelling on, because it is more than simple overloading. Yes, every extra kilogram multiplies the force through a knee with each step. But fat tissue is also metabolically active: it releases inflammatory signals that appear to accelerate cartilage breakdown throughout the body. That is why OA also shows up more often in the hands of people carrying excess weight, where load alone cannot be the explanation. It also means losing weight is one of the most effective things a person with knee OA can do — it both unloads the joint and turns down the inflammation.
OA is often dismissed as the joint simply “wearing out”, like a tyre. That framing is misleading and unhelpful. OA is now understood as an active process of the whole joint — cartilage, bone, synovium and ligaments all involved — with a real, if low-grade, inflammatory component, not just passive mechanical erosion. This matters because the “wear and tear” story implies you should rest and protect the joint, when in fact the evidence points the other way: appropriate movement and muscle strength protect cartilage and reduce pain. Joints are not tyres; they are living tissue that responds to use.
Rheumatoid & autoimmune arthritis
Rheumatoid arthritis (RA) is a fundamentally different beast. It is not wear; it is the immune system attacking the joints. For reasons still not fully understood — a mix of genetic susceptibility and triggers such as smoking and infection — the immune system turns on the synovium, the thin lining of the joint. The synovium becomes inflamed, thickened and overgrown into an aggressive tissue (a pannus) that invades and destroys the cartilage and bone beneath. The NHS rheumatoid arthritis pages describe the course.
Three features set RA apart from OA. It is typically symmetrical — the same knuckles on both hands, both wrists — where OA is often lopsided, following whichever joint was worked or injured. It causes prolonged morning stiffness, often lasting more than an hour, where OA's stiffness eases within minutes of moving. And, crucially, it is systemic: because the problem is the immune system rather than one worn joint, RA can cause fatigue, low fever, weight loss, and inflammation beyond the joints — in the lungs, eyes, blood vessels and heart. It is a whole-body disease that happens to show itself most in the joints.
The single most important idea in modern RA care is the window of opportunity. Once the immune assault has destroyed cartilage and eroded bone, that damage is permanent — you cannot grow it back. But in the first months, before erosions set in, aggressive treatment can switch the disease off and prevent the deformity that earlier generations took as RA's inevitable end. This is why rheumatologists now treat early and hard, and why a swollen, symmetrical, persistently stiff set of small joints is something to get checked quickly rather than wait out. The same urgency applies to the other inflammatory types — psoriatic arthritis, ankylosing spondylitis, the arthritis of lupus — which share the autoimmune machinery and the same logic of treating early to protect the joint.
Symptoms & diagnosis
The cardinal symptoms across the arthritides are pain, stiffness and swelling, sometimes with warmth, redness and a reduced range of movement. But the pattern of those symptoms is what lets a clinician tell the types apart, often before any test. The clearest tell is the stiffness: in OA, morning stiffness is brief, usually under half an hour, and pain comes on with use and eases with rest. In inflammatory arthritis like RA, morning stiffness is prolonged — often well over an hour — and the joints can feel better with gentle movement and worse after resting.
Diagnosis then layers on tests. X-rays show the structural signs — the narrowed joint space and osteophytes of OA, or the bony erosions of established RA. Blood tests are central to sorting the inflammatory types: CRP (and ESR) measure general inflammation; rheumatoid factor and the more specific anti-CCP antibodies point to rheumatoid arthritis; and a raised serum urate supports a diagnosis of gout (though the surest test for gout is finding urate crystals in fluid drawn from the joint). Ultrasound and MRI can reveal inflammation and early damage that an X-ray misses.
A few clues help tell immune-driven (inflammatory) arthritis from the mechanical wear of OA. Inflammatory pain tends to be worse after rest and in the early morning, comes with prolonged stiffness, eases with movement, and the joints look visibly swollen, warm and red — and there may be whole-body symptoms like fatigue. Mechanical pain is the reverse: worse with use and at the end of the day, better with rest, with only brief stiffness and little systemic upset. It is not foolproof, but it is the pattern a doctor reaches for first — and inflammatory clues are a reason to seek assessment sooner rather than later.
A short history
Arthritis is older than medicine — it is written into the skeletons of Egyptian mummies, Neanderthals and even dinosaurs. The word itself is Greek, arthron (joint) and -itis (inflammation), and the physicians of antiquity already distinguished some of the patterns we still name today.
Gout has the richest backstory. Recognised since antiquity and long called the “disease of kings” (and the “king of diseases”), it was associated with the rich diet and heavy drinking only the wealthy could afford — an association that turned out to have a real biochemical basis in how the body handles urate. The connection to uric-acid crystals was worked out in the nineteenth century, making gout one of the first forms of arthritis whose cause was genuinely understood. The NHS gout pages cover the modern picture.
Rheumatoid arthritis was teased apart from the general muddle of “rheumatism” and given its modern name in the nineteenth century. A turning point came in the 1940s with the discovery of rheumatoid factor — an antibody in the blood of many RA patients — the first hint that RA was an immune disease rather than an infection or simple wear.
The most dramatic chapter is cortisone. In 1948–49, researchers at the Mayo Clinic gave the newly isolated adrenal hormone to a woman crippled by RA, and within days she walked. The effect seemed miraculous, and the work won a Nobel Prize in 1950. Steroids turned out to have serious long-term side effects and were no cure, but they proved decisively that inflammation could be switched off chemically — and they launched the modern pharmacological era of rheumatology. The final transformation came from the late 1990s with the biologics revolution: precisely engineered drugs that block single inflammatory signals (the first targeted a molecule called TNF). For inflammatory arthritis, these changed the prognosis from near-inevitable disability to, for many, a controlled disease and a normal life.
Current approaches to treatment
Because the types differ so much, so does their treatment — but a few threads run through all of them. The aims are the same everywhere: relieve pain, preserve function and movement, and (for the inflammatory types) stop the disease damaging the joint.
- Exercise and physiotherapy. Counter-intuitively, the single most evidence-backed treatment for osteoarthritis is movement. Strengthening the muscles around a joint, keeping it mobile and staying active reduce pain and protect function. Rest weakens the supporting muscles and tends to make things worse. Cushioned, rocker-soled footwear can take load off painful knee, hip and foot joints.
- Weight management. For OA of the knees and hips, losing excess weight unloads the joint and lowers inflammation — one of the most effective interventions there is.
- Pain relief. Simple analgesics, anti-inflammatory drugs (NSAIDs such as ibuprofen, oral or as a topical gel rubbed into the joint) and other measures manage symptoms. These ease pain but do not change the course of the disease.
- Disease-modifying drugs (DMARDs). The backbone of inflammatory arthritis. Methotrexate is the usual first choice in RA — it dampens the overactive immune response and, taken early, can halt joint damage.
- Biologics and JAK inhibitors. When standard DMARDs are not enough, targeted drugs block specific inflammatory signals — anti-TNF agents and others — while newer JAK inhibitors are tablets that interrupt inflammation inside the cell. These transformed the outlook for severe RA, psoriatic arthritis and ankylosing spondylitis.
- Urate-lowering therapy. Gout is the most treatable type: allopurinol lowers the body's urate so crystals dissolve and attacks stop, while attacks themselves are settled with anti-inflammatories or colchicine.
- Joint injections. Steroid injections can calm a badly inflamed joint for a time.
- Joint replacement surgery. When a hip or knee is worn out and pain is severe, replacing it with an artificial joint is one of modern medicine's most reliably successful operations, restoring mobility and ending pain for hundreds of thousands of people each year.
| Drug category | What it does | Mainly used in |
|---|---|---|
| Analgesics / NSAIDs | Relieve pain and inflammation; symptom control only | All types |
| Topical NSAIDs | Anti-inflammatory gel applied over the joint | Osteoarthritis (esp. hands, knees) |
| Corticosteroids | Powerfully suppress inflammation (oral, or injected into a joint) | Flares of inflammatory arthritis |
| DMARDs (e.g. methotrexate) | Dampen the immune response; slow or stop joint damage | Rheumatoid, psoriatic, others |
| Biologics (e.g. anti-TNF) | Block a specific inflammatory signal | Severe inflammatory arthritis |
| JAK inhibitors | Tablets blocking inflammation signalling inside cells | Inflammatory arthritis not controlled by DMARDs |
| Urate-lowering (allopurinol) | Lower uric acid so crystals dissolve and stop forming | Gout |
What the research says & the frontiers
The contrast between the two great families of arthritis is starkest in the research. For inflammatory arthritis, the last quarter-century has been a genuine triumph. The biologics revolution, combined with a strategy called treat-to-target — setting a measurable goal of remission or low disease activity and adjusting drugs relentlessly until it is reached — means that many people with RA who would once have been disabled now lead ordinary lives. Early, aggressive, target-driven treatment is the established standard, and the toolkit of targeted drugs keeps growing.
Osteoarthritis is the harder, unsolved problem. There is, as yet, no drug proven to reverse or even reliably halt the underlying cartilage loss — OA's equivalent of a DMARD remains elusive. Current treatment manages symptoms and, at the end of the road, replaces the joint. The frontiers are aimed squarely at this gap: disease-modifying osteoarthritis drugs in trials; regenerative approaches — cartilage repair, cell and tissue-engineering techniques — that try to rebuild rather than just relieve; and a deeper understanding of OA as an active, inflammatory whole-joint disease, which opens new targets. None is yet a routine cure, and claims in this area should be treated with caution, but the direction is set. For balanced summaries of where the evidence stands, the research pages of Versus Arthritis, the Arthritis Foundation and NIAMS are sober and reliable.
Where to get help & more info
If your joints are persistently painful, stiff or swollen — and especially if the stiffness is prolonged in the mornings, the swelling is symmetrical, or there are whole-body symptoms — see a doctor rather than waiting it out. For inflammatory arthritis in particular, early treatment genuinely changes the outcome.
- NHS — Arthritis (overview)
- NHS — Osteoarthritis
- NHS — Rheumatoid arthritis
- NHS — Gout
- Versus Arthritis (UK charity — information and support)
- Arthritis Foundation (US)
- NIAMS (US National Institutes of Health)
- World Health Organization and the CDC for global and population data
Some of the figures and details on this page — typical ranges, statistics and the biology — were compiled with the help of AI tools and may contain errors or be out of date. They are shared in good faith for general interest only, and are not medical advice. Nothing here is a substitute for a doctor or a qualified health professional; if you are worried about your health, please seek professional help. Check claims against primary medical sources before relying on them.